View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Fluorouracil 500 / Epirubicin 90 / Cyclophosphamide 600 / Trastuzumab 6 / Pertuzumab 420, Breast Cancer, neoadjuvant, cycle 2-3
Protocol-ID: 1468 V1.0 (Mini), FEC (FU500/EPIR90/CYCL600)/TRAS6/PERT420, Breast Ca, neoadj., C2-3Indication(s)
- Breast Cancer (HER2+); ICD-10 C50.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 28.03.2020